Linezolid vancomycin resistant Enterococcus isolated from clinical samples in Tehran hospitals.
Indian J Med Sci
;
2009 July; 63(7) 297-302
Artículo
en Inglés
| IMSEAR
| ID: sea-145423
ABSTRACT
Background:
Vancomycin-resistant enterococci pose an emerging health risk. The limitation in therapeutic options has resulted in the development of new drugs such as quinupristin/ dalfopristin and linezolid. Aim, Setting andDesign:
This study investigated the species prevalence and antibacterial resistance among enterococci isolated in selected Tehran hospitals. Materials andMethods:
Between March 2006 and August 2007, 200 enterococcal isolates from urine, blood, stool and wound were recovered in 2 teaching hospitals of Tehran province. Susceptibility of all isolates was tested against vancomycin, teicoplanin and linezolid antibiotics by disk diffusion and agar dilution method. Results andConclusion:
Seventeen (8.5%), 6 (3%) and 4 (2%) of the isolates were resistant to vancomycin, teicoplanin and linezolid, respectively. Within the vancomycin-resistant isolates, 6 (35.2%), 4 (25%) and 1 (5.88%) showed vanA, vanB and vanC genotype patterns, respectively. Four (23.5%) of VRE isolates were resistant to linezolid with minimum inhibitory concentrations between 16 and 32 µg/mL. Two linezolid vancomycin resistant enterococci were E. faecium.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Humanos
/
Pruebas de Sensibilidad Microbiana
/
Prueba Bactericida de Suero
/
Prevalencia
/
Infecciones por Bacterias Grampositivas
/
Enterococcus
/
Teicoplanina
/
Resistencia a la Vancomicina
/
Oxazolidinonas
/
Farmacorresistencia Bacteriana Múltiple
Tipo de estudio:
Estudio de prevalencia
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Indian J Med Sci
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS